HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Santica M Marcovina Selected Research

Apoprotein(a) (Apolipoprotein (a))

1/2021Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a).
1/2019Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
1/2018Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics.
1/2017CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.
5/2013Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children.
4/2009Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
11/2008Lipoprotein(a) level as a predictor of cardiovascular disease and small apoliprotein(a) isoforms in dialysis patients: assay-related differences are important.
4/2007Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease.
1/2005Factors associated with lipoprotein(a) in chronic kidney disease.
8/2004Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Santica M Marcovina Research Topics

Disease

34Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2002
20Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 04/2006
18Type 2 Diabetes Mellitus (MODY)
11/2022 - 11/2002
12Atherosclerosis
01/2022 - 12/2002
11Coronary Disease (Coronary Heart Disease)
05/2018 - 08/2002
10Thrombosis (Thrombus)
01/2022 - 06/2003
9Inflammation (Inflammations)
01/2022 - 06/2010
9Insulin Resistance
01/2019 - 12/2006
7Myocardial Infarction
11/2019 - 06/2005
6Stroke (Strokes)
11/2019 - 06/2005
6Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2018 - 10/2013
6Coronary Artery Disease (Coronary Atherosclerosis)
04/2014 - 11/2003
5Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 10/2015
5Ischemic Stroke
05/2018 - 04/2004
5Obesity
01/2016 - 01/2009
4Hypoglycemia (Reactive Hypoglycemia)
11/2022 - 02/2016
4Dyslipidemias (Dyslipidemia)
01/2020 - 09/2010
4Vascular Diseases (Vascular Disease)
01/2018 - 04/2004
4Alzheimer Disease (Alzheimer's Disease)
12/2013 - 05/2005
4Chronic Renal Insufficiency
08/2005 - 12/2002
3Hypertension (High Blood Pressure)
01/2020 - 04/2007
3Genetic Risk Score
11/2018 - 12/2016
3Acute Coronary Syndrome
05/2018 - 09/2002
3Overweight
01/2016 - 03/2009
3Renal Insufficiency (Renal Failure)
08/2005 - 03/2002
3Kidney Diseases (Kidney Disease)
08/2005 - 12/2002
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2017
2Diabetes Complications
01/2021 - 03/2009
2Glucose Intolerance
01/2019 - 01/2016
2Diabetes Mellitus
01/2019 - 08/2017
2Pathologic Constriction (Stenosis)
04/2014 - 01/2013
2Heart Failure
07/2012 - 11/2002
2Venous Thrombosis (Deep-Vein Thrombosis)
09/2010 - 04/2004
2Hypercholesterolemia
04/2007 - 12/2002
2Chronic Kidney Failure (Chronic Renal Failure)
07/2003 - 11/2002
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
11/2022
1Disease Progression
01/2021
1Unstable Angina
11/2019
1Homozygous Familial Hypercholesterolemia
12/2018

Drug/Important Bio-Agent (IBA)

40Lipoprotein(a)IBA
01/2022 - 03/2002
22Apolipoproteins AIBA
01/2022 - 03/2002
15Apoprotein(a) (Apolipoprotein (a))IBA
01/2021 - 03/2002
15LipidsIBA
01/2020 - 11/2002
11Lipoproteins (Lipoprotein)IBA
01/2022 - 07/2003
10Triglycerides (Triacylglycerol)IBA
05/2018 - 01/2005
9LDL CholesterolIBA
01/2022 - 11/2002
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 09/2002
9C-Reactive ProteinIBA
11/2019 - 09/2002
9oxidized low density lipoproteinIBA
01/2018 - 12/2006
9Insulin (Novolin)FDA Link
10/2016 - 01/2008
9Protein Isoforms (Isoforms)IBA
05/2013 - 03/2002
7Apolipoproteins B (ApoB)IBA
01/2022 - 12/2006
7Biomarkers (Surrogate Marker)IBA
11/2019 - 03/2012
7ApolipoproteinsIBA
01/2017 - 05/2005
6Niacin (Nicotinic Acid)FDA LinkGeneric
11/2019 - 10/2013
6LDL Lipoproteins (beta Lipoproteins)IBA
01/2019 - 12/2006
5HDL CholesterolIBA
11/2019 - 01/2009
5Glucose (Dextrose)FDA LinkGeneric
01/2016 - 12/2006
5CholesterolIBA
01/2016 - 11/2003
4Fibrinogen (Factor I)FDA Link
11/2019 - 06/2010
4AutoantibodiesIBA
06/2015 - 07/2011
4AlbuminsIBA
01/2009 - 07/2003
3Interleukin-6 (Interleukin 6)IBA
11/2019 - 06/2010
3Metformin (Glucophage)FDA LinkGeneric
01/2019 - 01/2016
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2019 - 06/2010
3LeptinIBA
11/2018 - 12/2002
3Glucagon (Glukagon)FDA Link
10/2016 - 02/2016
2Simvastatin (Zocor)FDA LinkGeneric
11/2019 - 03/2018
2AdiponectinIBA
11/2018 - 12/2011
2Hemoglobins (Hemoglobin)IBA
01/2017 - 10/2011
2Apolipoprotein B-100 (Apo B 100)IBA
04/2016 - 04/2009
21-penicillamyl-Leu(2)- oxytocinIBA
07/2015 - 04/2009
2C-PeptideIBA
06/2015 - 03/2015
2Glycoproteins (Glycoprotein)IBA
07/2009 - 07/2003
2Phospholipids (Phosphatides)FDA LinkGeneric
04/2009 - 05/2005
2CreatinineIBA
01/2009 - 10/2007
2low density lipoprotein inhibitorIBA
03/2008 - 11/2002
2Glutamic Acid (Glutamate)FDA Link
10/2007 - 04/2006
2AutoantigensIBA
10/2007 - 04/2006
2Rosiglitazone (Avandia)FDA Link
12/2006 - 11/2002
2Serum AlbuminIBA
08/2005 - 01/2005
1Biological ProductsIBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2020
1Fibric Acids (Fibrates)IBA
01/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2020
1Fenofibrate (CiL)FDA LinkGeneric
01/2020
1CarbonIBA
11/2019
1Particulate MatterIBA
11/2019
1Ezetimibe (Zetia)FDA Link
11/2019
1Air Pollutants (Pollutants, Air)IBA
11/2019
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
11/2019
1Antisense OligonucleotidesIBA
12/2018
1mipomersenIBA
12/2018
1Insulin Glargine (Lantus)FDA Link
11/2018
1lipoprotein cholesterolIBA
05/2018

Therapy/Procedure

14Therapeutics
01/2021 - 11/2002
12Glycemic Control
11/2022 - 11/2002
1Ligation
01/2022
1Tertiary Prevention
01/2021
1Dietary Approaches To Stop Hypertension
01/2018